Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

Yael L. Maxwell

January 14, 2026

News Daily News

Occupational Hazard? CTO Cases Drive Up Operators’ BP, Heart Rates

Yael L. Maxwell

March 11, 2024

News Conference News VIVA 2023

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

L.A. McKeown

November 03, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

L.A. McKeown

June 07, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Conference News PCR London Valves 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News PCR London Valves 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Michael O'Riordan

November 25, 2021

News Features

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

L.A. McKeown

December 24, 2020

News Daily News

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

L.A. McKeown

September 18, 2020

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

Todd Neale

September 04, 2020

News Daily News

Kenneth Kent, Angioplasty Pioneer and Original TCT Co-Director, Dies at 81

Yael L. Maxwell

May 22, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Conference News TVT 2019

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Shelley Wood

June 19, 2019

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

Advertisement

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

Occupational Hazard? CTO Cases Drive Up Operators’ BP, Heart Rates

‘Dire’ Lack of Vascular Care in Underserved Areas Needs Creativity, Compassion

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

What Works, What’s Noise? Novel Approaches Offer Hope in CLTI

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

Implantation Technique Influences LV Remodeling After TMVR

Kenneth Kent, Angioplasty Pioneer and Original TCT Co-Director, Dies at 81

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Pascal Transcatheter Device Safe, Improves Tricuspid Regurgitation: Early Results

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content